HF  Viking Global Investors

https://www.vikingglobal.com/





     Office Locations:

55 Railroad Ave. #300
Greenwich, CT 06830
Phone: 203-863-5000

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Middle Market


 

Industries:

  • Financial Services
  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Viking Global Investors LP is a global investment firm founded in 1999. The firm manages approximately $50 billion of capital for our investors. Viking has offices in Greenwich, New York, Hong Kong, London and San Francisco and is registered as an investment adviser with the U.S. Securities and Exchange Commission. The firm uses fundamental analysis to select investments, primarily public and private equity interests, across industries and geographies. Viking generally invests in companies based on a thorough assessment of their business models and fundamentals, the quality of their management teams and cyclical and secular industry trends.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    David Truetzel Analyst
    Hans Reuter

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/02/2024


      Triveni Bio


      MA


      $115,000,000


      Series B


      07/19/2024


      Antheia


      CA


      $17,000,000


      


      06/11/2024


      AlphaSense


      NY


      $650,000,000


      Venture


      04/03/2024


      Diagonal Therapeutics


      MA


      $128,000,000


      Series A


      03/06/2024


      Sionna Therapeutics


      MA


      $182,000,000


      Series C


      02/13/2024


      Areteia Therapeutics


      NC


      $75,000,000


      Series A


      02/08/2024


      Neurona Therapeutics


      CA


      $120,000,000


      Venture


      01/04/2024


      Human Immunology Biosciences


      CA


      $95,000,000


      Series B


     

    Portfolio companies include:


      4D Molecular Therapeutics
        web link


      Adaptive Biotechnologies
        web link


      Affinivax
        web link


      Allonnia
        web link


      AlphaSense
        web link


      Amunix
        web link


      Amylyx Pharmaceuticals
        web link


      Antheia
        web link


      Apeel Sciences
        web link


      Arctic Wolf


      Areteia Therapeutics
        web link


      Astarte Medical
        web link


      Athira Pharma
        web link


      Auris Health
        web link


      Birchbox


      BridgeBio Pharma
        web link


      Checkerspot
        web link


      CloudBeds


      Color Genomics
        web link


      Credit Karma


      Day One Biopharmaceuticals
        web link


      Deciphera Pharmaceuticals
        web link


      DermBiont
        web link


      Diagonal Therapeutics
        web link


      Domo


      Druva


      Ecovative Design
        web link


      Editas Medicine
        web link


      Ensoma
        web link


      Ginkgo Bioworks


      HeadLight
        web link


      Human Immunology Biosciences
        web link


      Icosavax


      ID.me


      Impossible Foods
        web link


      Iterable


      Kinnate Biopharma
        web link


      Lightmatter
        web link


      Mantra Bio
        web link


      Moderna Therapeutics
        web link


      Neurona Therapeutics
        web link


      NextGen Jane
        web link


      Pearl Health
        web link


      PMV Pharma
        web link


      Pragma Bio
        web link


      Rallybio
        web link


      Sionna Therapeutics
        web link


      Solarea Bio
        web link


      Talaris Therapeutics
        web link


      Talkdesk
        web link


      Triveni Bio
        web link


      Vector BioMed
        web link


      VelosBio
        web link


      Vets First Choice


      Xcellbio
        web link


      Zentalis Pharmaceuticals
        web link


     

    Recent News: